Biofourmis Receives Significant Growth Investment from General Atlantic and Reaches Unicorn Status
Similar Posts
EnableComp acquires H/ROI to expand clinical denials and DRG validation services
Deal adds Northeast-based clinical denials expertise and post-bill DRG validation to EnableComp’s complex revenue cycle offerings EnableComp intends to…
Immunai Acquires Swiss Company Nebion To Expand Its Platform for Target Discovery and Drug Development
The company welcomes the Nebion team, Moderna co-founder Robert Langer as a Board Member, and world-renowned immunologist Jacques Banchereau…
